Showing results (101-110 of 176) with videos related to
Sort By:
Pageof 18
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 1, 2019
Efficacy of Platinum/Pemetrexed Combination Chemotherapy in ALK-Positive NSCLC Refractory to Second-Generation ALK InhibitorsJessica J Lin, Adam J Schoenfeld, Viola W Zhu, et al.International Journal of Radiation Oncology, Biology, Physics|February 8, 2018
Brainstem Injury in Pediatric Patients With Posterior Fossa Tumors Treated With Proton Beam Therapy and Associated Dosimetric FactorsMichelle S Gentile, Beow Y Yeap, Harald Paganetti, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|May 15, 2019
Long-term outcomes and late adverse effects of a prospective study on proton radiotherapy for patients with low-grade gliomaShervin Tabrizi, Beow Y Yeap, Janet C Sherman, et al.The Journal of Molecular Diagnostics : JMD|November 19, 2016
Validation of a Gene Expression Test for Mesothelioma Prognosis in Formalin-Fixed Paraffin-Embedded TissuesAssunta De Rienzo, Robert W Cook, Jeff Wilkinson, et al.Neuro-Oncology|June 10, 2020
Clinical outcomes in a large pediatric cohort of patients with ependymoma treated with proton radiotherapyBrooke E Patteson, Sujith Baliga, Benjamin V M Bajaj, et al.Lung Cancer (Amsterdam, Netherlands)|February 21, 2012
Frequent downregulation of the transcription factor Foxa2 in lung cancer through epigenetic silencingDaniela S Basseres, Francesco D'Alò, Beow Y Yeap, et al.Cancer Research|October 15, 2009
Lung adenocarcinoma with EGFR amplification has distinct clinicopathologic and molecular features in never-smokersLynette M Sholl, Beow Y Yeap, A John Iafrate, et al.Cancer|October 15, 2013
Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapyRoshan V Sethi, Helen A Shih, Beow Y Yeap, et al.Neurosurgery|March 1, 2022
Fractionated Proton Radiation Therapy and Hearing Preservation for Vestibular Schwannoma: Preliminary Analysis of a Prospective Phase 2 Clinical TrialAnurag Saraf, Luke R G Pike, Kevin H Franck, et al.The Journal of Clinical Investigation|August 15, 2006
Allelic dilution obscures detection of a biologically significant resistance mutation in EGFR-amplified lung cancerJeffrey A Engelman, Toru Mukohara, Kreshnik Zejnullahu, et al.Pageof 18